| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $98,7100 | +4,32 % | $1,44B | $74,99K | |
TMP Tompkins Financial Corporation | $98,8080 | -1,44 % | $1,44B | $16,81K | |
BRUN Boost Run Inc. Class A Common Stock | $18,3570 | -8,79 % | $1,44B | $949,16K | |
TWFG TWFG, Inc. Common Stock | $27,2150 | +1,62 % | $1,44B | $55,72K | |
PCT PureCycle Technologies, Inc. Common stock | $7,2480 | +5,35 % | $1,44B | $941,15K | |
REX REX American Resources Corp. | $44,0000 | -0,27 % | $1,43B | $16,15K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $8,0200 | -3,95 % | $1,43B | $19,95K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6000 | +0,04 % | $1,43B | $7,62K | |
ADNT Adient plc Ordinary Shares | $19,9610 | +2,47 % | $1,43B | $76,09K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04 % | $1,43B | $1,83M | |
| $37,4800 | -0,21 % | $1,43B | $145,04K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8930 | -7,28 % | $1,43B | $293,10K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $17,3010 | +1,71 % | $1,42B | $17,26K | |
REPL Replimune Group, Inc. | $14,9300 | -4,17 % | $1,42B | $1,30M | |
HCSG Healthcare Services Group | $23,3650 | +6,50 % | $1,42B | $188,49K | |
